“The want of performance of an obligation, or of an offer

New Post Public Reply Private Reply Replies (0) Message Board
Long Term
1,152
“The want of performance of an obligation, or of an offer of performance, in whole or in part, or any delay therein, is excused by the following causes, to the extent to which they operate: (2) When it is prevented or delayed by an irresistible, superhuman cause, or by the act of public enemies of this state or of the United States, unless the parties have expressly agreed to the contrary.”4 Even if not entirely impossible to perform, if it is utterly impractical to perform, the same result obtains—performance of contractual duties may be excused.

&
5. Is a delay in performance rather than a suspension of the entire contract merited? From an objective standpoint, a delay in performance is far less drastic than a termination of all contractual rights. It may be more plausible to take that position, at least at the outset as events unfold, reserving the right to seek to be excused from the entire obligation.”

If I recall correctly the contract stated 5M due Oct (1?) 2020…..
This contract & court filing were both agreed & filings occurred more than 5(?) yrs ago…thus totally unforeseen event that prevented the (courts) process from moving on in their normal timetable.
It also stated after that date ( Oct 1 (?)….. interest would be applied at a rate of 25,000 (?) / month.
,” a delay in performance is far less drastic than a termination of all contractual rights”
The interest rate agreed upon meets the “far less drastic” option of ….”total to be excused from the entire obligation.”
From first paragraph: (2) When it is prevented or delayed by an irresistible, superhuman cause, or by the act of public enemies of this state or of the United States, unless the parties have expressly agreed to the contrary.”4
The question is a pandemic produce the same condition = …”delayed by an irresistible, superhuman cause, or by the act of public enemies of this state or of the United States”
Need to review foot note # 4 “ 4 Cal. Civ. Code § 1511.”……anyone have this?

On this reading it appears the question to the court is:
1. Does … “…”delayed by an irresistible, superhuman cause, or by the act of public enemies of this state or of the United States” meet the standard as stated IE: pandemic = to war delays?
2. Is there in the contract a less drastic solution than…. “a termination of all contractual rights”…… the court might recognize the agreement in the contract that would prevent cancelation of the contract…that would be the interest rate..25,000 / mo




https://www.dorsey.com/newsresources/publicat...e-disputes

UnifiedOnline, Inc. (UOIP) Stock Research Links

UOIP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 17

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 9

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 8

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 11

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 19

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 19

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Magna5 Secures 39th Spot on Inc.'s Prestigious Rankings

Updated Category News Views 245

Magna5 Achieves Recognition in Inc. Rankings In a proud moment for the team, Magna5 has ranked No. 39 on the coveted Inc. Regionals: Northeast list. This annual evaluation highlights the fastest-growing private companies within this region, emphasizing the remarkable impact of independent small businesses in various sectors. The company’s recognition showcases its...

Continue Reading
Appian Shines as a Leader in Process Orchestration Assessment

Updated Category News Views 236

Appian Recognized as a Leader in Process Orchestration Appian has made headlines recently by being named a leader in a prominent assessment of process orchestration products. This recognition by Everest Group positions Appian at the forefront of innovations that empower businesses to enhance their operational workflows and increase efficiency. What Is Process...

Continue Reading
Financial Institutions Reports Strong EPS Beat, Price Target Held

Updated Category News Views 195

Analysis of Financial Institutions’ Recent Performance Recently, Financial Institutions (NASDAQ:FISI) received an Equal Weight rating from Stephens, reaffirming a price target of $28.50. The company delivered impressive financial results, with earnings per share (EPS) reported at $0.84 for GAAP and $0.82 for operating earnings. These figures exceeded both the company's...

Continue Reading
United Airlines Earnings Preview: Analyst Upgrades and Insights

Updated Category News Views 168

United Airlines Earnings Report Overview United Airlines Holdings, Inc. (NASDAQ: UAL) is on the brink of announcing its third-quarter earnings results. Investors and analysts alike are eagerly anticipating these numbers, especially as the company is projected to report a decrease in earnings per share compared to the previous year. Expected Earnings Decline Analysts...

Continue Reading
Ontex's Strategic Share Buyback Program Overview

Updated Category News Views 114

Ontex's Strategic Share Buyback Program Ontex is making headlines with its ongoing program to acquire treasury shares, which marks a significant move for the company. The decision to initiate this buyback was formally disclosed in accordance with the regulations established by the Belgian government. This proactive strategy is designed to enhance shareholder value and...

Continue Reading